Jailendra Singh
Stock Analyst at Truist Securities
(0.87)
# 3,890
Out of 4,996 analysts
184
Total ratings
26.04%
Success rate
-22.19%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Buy | $35 → $36 | $23.62 | +52.41% | 7 | Sep 8, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $58.40 | -36.64% | 11 | Aug 18, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $187 → $234 | $163.79 | +42.87% | 10 | Jul 25, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $298 → $436 | $496.79 | -12.24% | 5 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $209 → $235 | $179.56 | +30.88% | 16 | Jul 23, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $37.56 | +35.78% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $21.46 | +25.82% | 10 | Jul 17, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $16 | $8.95 | +78.77% | 6 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $74.40 | -18.01% | 9 | Jul 17, 2025 | |
| HNGE Hinge Health | Initiates: Buy | $48 | $48.46 | -0.95% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $8.16 | +10.29% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $23.98 | +16.76% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $4.04 | +36.14% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $6.20 | +20.97% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $29.68 | +54.99% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $290.27 | -27.65% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $10.88 | +28.68% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $1.09 | +496.33% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $3.94 | +229.95% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $4.77 | +801.47% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $3.98 | +503.02% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $2.03 | +97.04% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $153.71 | -62.27% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $4.53 | +893.38% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $760.55 | -56.22% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $3.20 | +181.25% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $27.81 | - | 3 | Jan 15, 2021 |
Phreesia
Sep 8, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $23.62
Upside: +52.41%
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $58.40
Upside: -36.64%
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $187 → $234
Current: $163.79
Upside: +42.87%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $298 → $436
Current: $496.79
Upside: -12.24%
IQVIA Holdings
Jul 23, 2025
Maintains: Buy
Price Target: $209 → $235
Current: $179.56
Upside: +30.88%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $37.56
Upside: +35.78%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $21.46
Upside: +25.82%
Evolent Health
Jul 17, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $8.95
Upside: +78.77%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $74.40
Upside: -18.01%
Hinge Health
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $48.46
Upside: -0.95%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $8.16
Upside: +10.29%
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $23.98
Upside: +16.76%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $4.04
Upside: +36.14%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $6.20
Upside: +20.97%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $29.68
Upside: +54.99%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $290.27
Upside: -27.65%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $10.88
Upside: +28.68%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $1.09
Upside: +496.33%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $3.94
Upside: +229.95%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $4.77
Upside: +801.47%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $3.98
Upside: +503.02%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $2.03
Upside: +97.04%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $153.71
Upside: -62.27%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $4.53
Upside: +893.38%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $760.55
Upside: -56.22%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $3.20
Upside: +181.25%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $27.81
Upside: -